Agency Information Collection Activities; Announcement of Office of Management and Budget; Extension of Expiration Date for MedWatch (Food and Drug Administration Medical Products Reporting Program) Form, 62593-62594 [E6-17907]
Download as PDF
62593
Federal Register / Vol. 71, No. 207 / Thursday, October 26, 2006 / Notices
Trans No.
Acquiring
Acquired
Entities
20061845 .....
Tenaska Power Fund, L.P .......................
William J. Haugland .................................
20061848 .....
20061857 .....
Corel Holdings, L.P ..................................
Wind Point Partners VI, L.P .....................
InterVideo, Inc ..........................................
Spire Capital Partners, L.P ......................
20061858 .....
Citizens Communications Company ........
20061863
20061870
20061872
20070003
Edmund N. Ansin .....................................
Illinois Tool Works, Inc .............................
Canadian Natural Resources, Limited .....
Hospitality Properties Trust ......................
Commonwealth Telephone Enterprises,
Inc.
Tribune Company ....................................
Click Commerce, Inc ................................
Anadarko Petroleum Corporation ............
Oak Hill Capital Partners, L.P ..................
Bemis, LLC., Halpin Line Construction,
LLC., Hawkeye Group, LLC. Premier
Utility Locating, LLC.
InterVideo, Inc.
Highline Data, LLC., The National Underwriter Company.
Commonwealth Telephone Enterprises,
Inc.
WLVI, Inc.
Click Commerce, Inc.
Anadarko Canada Corporation.
TravelCenters of America, Inc.
.....
.....
.....
.....
Transactions Granted Early Termination—10/11/2006
20061810
20061849
20061869
20061871
.....
.....
.....
.....
AT&T, Inc .................................................
John C. Hampton Revocable Trust .........
Issac E. Larian and Angela Larian ..........
BB&T Corporation ....................................
Interpath Communications, Inc ................
West Fraser Timber Co., Ltd ...................
Newell Rubbermaid Inc ............................
Mellon Financial Corporation ...................
Interpath Communications, Inc.
Babine Forest Products, Limited.
The Little Tikes Company, Inc.
AFCO Credit Corporation.
Transactions Granted Early Termination—10/13/2006
20061803 .....
Medical Action Industries, Inc ..................
FOR FURTHER INFORMATION CONTACT:
Sandra M. Peay, Contact Representative,
or Renee Hallman, Contact
Representative, Federal Trade
Commission, Premerger Notification
Office, Bureau of Competition, Room H–
303, Washington, DC 20580, (202) 326–
3100.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 06–8901 Filed 10–25–06; 8:45 am]
BILLING CODE 6750–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
[Document Identifier: OS–0990–000]
ycherry on PROD1PC64 with NOTICES
30-Day Notice; Agency Information
Collection Activities: Proposed
Collection; Comment Request
Agency: Office of the Secretary.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Office of the Secretary (OS), Department
of Health and Human Services, is
publishing the following summary of a
proposed collection for public
comment. Interested persons are invited
to send comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
VerDate Aug<31>2005
15:21 Oct 25, 2006
Jkt 211001
Medegen Holdings, LLC ..........................
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Type of Information Collection
Request: Regular, New Collection.
Title of Information Collection: The
Effect of Reducing Falls on Acute and
Long-Term Care Expenses.
Form/OMB No.: OS–0990–New.
Attention: ASPE is planning to
conduct a demonstration and evaluation
of a multi-factorial fall prevention
program to measure its impact on health
outcomes for the elderly as well as acute
and long-term care use and cost. This
will be accomplished by obtaining a
sample of individuals with private longterm care insurance who are age 75 and
over.
Frequency: One Time On Occasion.
Affected Public: Individual or
Households.
Annual Number of Respondents:
9720.
Total Annual Responses: 9,600.
Average Burden Per Response: 3.54
min.
Total Annual Hours: 4305.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, e-mail your request,
including your address, phone number,
OMB number, and OS document
identifier, to
Sherette.funncoleman@hhs.gov, or call
the Reports Clearance Office on (202)
690–6162. Written comments and
recommendations for the proposed
information collections must be
PO 00000
Frm 00013
Fmt 4703
Sfmt 4703
Medegen Newco, LLC.
received within 30 days of this notice
directly to the
Desk Officer at the address below:
OMB Desk Officer: John Kraemer,
OMB Human Resources and Housing
Branch, Attention: (OMB #0990–New),
New Executive Office Building, Room
10235, Washington, DC 20503.
Dated: October 23, 2006.
Alice Bettencourt,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. E6–17943 Filed 10–25–06; 8:45 am]
BILLING CODE 4151–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004N–0535]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget; Extension of
Expiration Date for MedWatch (Food
and Drug Administration Medical
Products Reporting Program) Form
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; extension of expiration
date.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that, under the Paperwork Reduction
Act of 1995 (the PRA), the Office of
Management and Budget (OMB) has
extended the expiration date to May 1,
2007, for the use of the prior version of
Form FDA 3500A for ‘‘MedWatch: Food
and Drug Administration Medical
E:\FR\FM\26OCN1.SGM
26OCN1
62594
Federal Register / Vol. 71, No. 207 / Thursday, October 26, 2006 / Notices
unless it displays a currently valid OMB
control number.
FOR FURTHER INFORMATION CONTACT:
ycherry on PROD1PC64 with NOTICES
Products Reporting Program’’ (the
MedWatch Program).
Dated: October 19, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–17907 Filed 10–25–06; 8:45 am]
Elizabeth Berbakos, Office of
Management Programs (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
1482.
SUPPLEMENTARY INFORMATION: In the
Federal Register of August 16, 2005 (70
FR 48157), FDA announced that a
proposed collection of information
entitled ‘‘MedWatch: Food and Drug
Administration Medical Products
Reporting Program’’ had been submitted
to OMB for approval under the PRA.
The collection of information included
the use of two forms used in the
MedWatch Program—Form FDA 3500
and Form FDA 3500A. In that notice, we
responded to public comments
pertaining to proposed revisions to
Form FDA 3500 and Form FDA 3500A.
Several comments from industry stated
that considerable resources would be
required to modify computer systems
and processes to begin using the
mandatory reporting form—Form FDA
3500A. In response to these comments,
we stated: ‘‘[T]o allow mandatory
reporters time to make the necessary
changes to their computer systems and
processes to conform to the revised
Form FDA 3500A, FDA is granting a
grace period of 1 year. During this
transition period FDA will accept both
the newly effective Form FDA 3500A
and the prior version of the form.’’
In the Federal Register of December 7,
2005 (70 FR 72843), FDA announced
that OMB had approved the information
collection for the MedWatch Program as
submitted to OMB on August 16, 2005.
In that notice, we stated: ‘‘As requested
by the agency, in addition to the
approval of the revised forms, the
existing forms are approved for
continued use for the next 12 months to
allow for the industry to make necessary
changes to their computerized systems.’’
In response to several recent requests
from industry that we grant more time
to make necessary changes to
computerized systems, we requested
and OMB has agreed to extend approval
to use the prior version of Form FDA
3500A until May 1, 2007. The
expiration date for the newly revised
Form FDA 3500A remains unchanged—
October 31, 2008. The prior version of
Form FDA 3500A is available for
downloading at https://www.fda.gov/
medwatch/getforms.htm, and the
expiration date on the form has been
revised to May 1, 2007.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
VerDate Aug<31>2005
15:21 Oct 25, 2006
Jkt 211001
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Dental Products Panel of the Medical
Devices Advisory Committee; Notice of
Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). At least one portion of the
meeting will be closed to the public.
Name of Committee: Dental Products
Panel of the Medical Devices Advisory
Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on November 9, 2006, from 8 a.m.
to 5 p.m.
Location: Holiday Inn, Walker/
Whetstone Rooms, Two Montgomery
Village Ave., Gaithersburg, MD.
Contact Person: Michael J. Ryan,
Center for Devices and Radiological
Health (HFZ–480), Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850, 301–827–5283,
ext. 175, e-mail at:
michael.ryan@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), code
3014512518. Please call the Information
Line for up-to-date information on this
meeting.
Agenda: The committee will discuss,
make recommendations, and vote on a
premarket approval application for a
collagen material, which contains a
bone morphogenetic protein, for oral
maxillofacial bone grafting procedures.
Background information, including the
agenda and questions for the committee,
will be available to the public 1
business day before the meeting on the
Internet at https://www.fda.gov/cdrh/
panel (click on Upcoming CDRH
Advisory Panel/Committee Meetings).
Procedure: On November 9, 2006,
from 8:30 a.m. to 5 p.m., the meeting
will be open to the public. Interested
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
persons may present data, information,
or views, orally or in writing, on issues
pending before the committee. Written
submissions may be made to the contact
person on or before November 2, 2006.
Oral presentations from the public will
be scheduled for approximately 30
minutes at the beginning of committee
deliberations and for approximately 30
minutes near the end of the
deliberations. Time allotted for each
presentation may be limited. Those
desiring to make formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before
November 2, 2006.
Closed Committee Deliberations: On
November 9, 2006, from 8 a.m. to 8:30
a.m., the meeting will be closed to the
public to permit FDA to present to the
committee trade secret and/or
confidential commercial information
regarding pending and future agency
issues (5 U.S.C. 552b(c)(4)) for the next
year.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact AnnMarie
Williams, Conference Management
Staff, 301–827–7291, at least 7 days in
advance of the meeting.
FDA regrets that it was unable to
publish this notice 15 days prior to the
Dental Products Panel of the Medical
Devices Advisory Committee meeting.
Because the agency believes there is
some urgency to bring these issues to
public discussion and qualified
members of the Dental Products Panel of
the Medical Devices Advisory
Committee were available at this time,
the Commissioner of Food and Drugs
concluded that it was in the public
interest to hold this meeting even if
there was not sufficient time for the
customary 15-day public notice.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
E:\FR\FM\26OCN1.SGM
26OCN1
Agencies
[Federal Register Volume 71, Number 207 (Thursday, October 26, 2006)]
[Notices]
[Pages 62593-62594]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-17907]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004N-0535]
Agency Information Collection Activities; Announcement of Office
of Management and Budget; Extension of Expiration Date for MedWatch
(Food and Drug Administration Medical Products Reporting Program) Form
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; extension of expiration date.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that,
under the Paperwork Reduction Act of 1995 (the PRA), the Office of
Management and Budget (OMB) has extended the expiration date to May 1,
2007, for the use of the prior version of Form FDA 3500A for
``MedWatch: Food and Drug Administration Medical
[[Page 62594]]
Products Reporting Program'' (the MedWatch Program).
FOR FURTHER INFORMATION CONTACT: Elizabeth Berbakos, Office of
Management Programs (HFA-250), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-1482.
SUPPLEMENTARY INFORMATION: In the Federal Register of August 16, 2005
(70 FR 48157), FDA announced that a proposed collection of information
entitled ``MedWatch: Food and Drug Administration Medical Products
Reporting Program'' had been submitted to OMB for approval under the
PRA. The collection of information included the use of two forms used
in the MedWatch Program--Form FDA 3500 and Form FDA 3500A. In that
notice, we responded to public comments pertaining to proposed
revisions to Form FDA 3500 and Form FDA 3500A. Several comments from
industry stated that considerable resources would be required to modify
computer systems and processes to begin using the mandatory reporting
form--Form FDA 3500A. In response to these comments, we stated: ``[T]o
allow mandatory reporters time to make the necessary changes to their
computer systems and processes to conform to the revised Form FDA
3500A, FDA is granting a grace period of 1 year. During this transition
period FDA will accept both the newly effective Form FDA 3500A and the
prior version of the form.''
In the Federal Register of December 7, 2005 (70 FR 72843), FDA
announced that OMB had approved the information collection for the
MedWatch Program as submitted to OMB on August 16, 2005. In that
notice, we stated: ``As requested by the agency, in addition to the
approval of the revised forms, the existing forms are approved for
continued use for the next 12 months to allow for the industry to make
necessary changes to their computerized systems.'' In response to
several recent requests from industry that we grant more time to make
necessary changes to computerized systems, we requested and OMB has
agreed to extend approval to use the prior version of Form FDA 3500A
until May 1, 2007. The expiration date for the newly revised Form FDA
3500A remains unchanged--October 31, 2008. The prior version of Form
FDA 3500A is available for downloading at https://www.fda.gov/medwatch/
getforms.htm, and the expiration date on the form has been revised to
May 1, 2007.
An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid OMB control number.
Dated: October 19, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-17907 Filed 10-25-06; 8:45 am]
BILLING CODE 4160-01-S